News | December 02, 2007

PharMEDium Offers Pre-Filled OR Perioperative Compounded Drugs

December 3, 2007 - Outsourced hospital compounded sterile preparations maker PharMEDium Services LLC said today it is offering compounded pre-filled, perioperative anesthesia drugs, an effort devoted to reducing medication errors and improving OR efficiencies.

The service line covers the most commonly used drugs in the OR, including about 75 percent of those typically used in surgical procedures.

Compounded ready-to-use preparations address a host of OR risk factors, such as “look-alike” vials, syringes, and high-risk medications that lack labels and bar codes, all which contribute to medication errors.

The service line uses labels for anesthesiology conforming to standards of the American Society for Testing and Materials (ASTM). To enhance drug recognition, PharMEDium color-codes syringe preparations by class (orange for sedatives, red for neuromuscular blocking agents, blue for narcotics, etc.) consistent with the ASTM standards. Drug names are color-coded and dual-banded (so physicians can see the drug name on a syringe from any angle), and shapes on labels assist in distinguishing concentrations of drugs within families. Labels show an RSS composite bar code, including NDC number, lot, and expiration date, so hospitals can reportedly better track and reconcile high-risk drugs, enhance inventory control, and reduce unused or wasted drug admixtures.

For more information: www.pharmedium.com

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init